Introduction
Poly(ADP-ribose) polymerases (PARPs) represent a vital family of enzymes crucial in various cellular processes, particularly in the DNA damage response (DDR). With their role in mediating ADP-ribosylation through the substrate NAD⁺, these enzymes significantly influence chromatin structure and transcriptional regulation. The diverse functions of human PARP family members underscore their importance in therapeutic targets, particularly concerning cancer treatment.
Understanding PARP Inhibition in Cancer Therapy
The inhibition of PARP enzymes, particularly PARP1 and PARP2, has emerged as a strategic approach in cancer therapy. By obstructing single-strand break DNA repair mechanisms, these inhibitors induce synthetic lethality, particularly in cancers characterized by defective homologous recombination, such as BRCA-mutated tumors. This has ushered in a new era of PARP inhibitors as effective cancer treatments, with ongoing research expanding the scope of potential PARP targets beyond the traditional focus.
Comprehensive PARP Screening Services
Creative Bioarray offers a suite of in vitro PARP screening services designed to expeditiously evaluate the inhibitory potential of various compounds. This comprehensive service suite aids researchers in optimizing drug candidates during the early stages of drug discovery, ensuring efficient and effective identification of promising PARP inhibitors.
Key Services Offered
- PARP Inhibitor Screening: Comprehensive assessments to determine the efficacy of compounds against PARP enzymes.
- Single-point Concentration and IC50 Determination: Accurate measurement of inhibitor potency.
Assay Details
- Biochemical Catalytic Inhibition: Recombinant PARP enzymes catalyze the ADP-ribosylation of substrates. Inhibitors work by blocking NAD⁺ consumption or hindering ADP-ribose transfer.
- PARP–DNA Trapping (Fluorescence Polarization): Utilizing fluorescently labeled DNA, this assay monitors binding activity. Inhibitors that promote PARP trapping exhibit increased fluorescence polarization signals.
Target List
The following targets are available for screening:
- PARP1
- PARP2
- PARP3
- PARP5A/B
- PARP7
- PARP8
- PARP10
- PARP11
- PARP12
- PARP14
- PARP15
- ARH3
- PARG
Additional members can be incorporated upon request.
Advantages of Our Services
- High-throughput Capability: Utilizing automated platforms, our services support rapid compound screening, significantly reducing the time needed for evaluations.
- Data Integrity: Relying on validated methods and strict industry standards ensures accurate and reproducible results.
- Customizable Solutions: Tailored to meet specific project requirements, including targeting particular PARP subtypes or varying concentration gradients.
- Expert Support: Our experienced team provides ongoing support, adapting services to fit the unique needs of your research.
Conclusion
The innovative PARP screening services offered by Creative Bioarray serve as an invaluable asset in the realm of drug discovery. By enabling rapid identification and optimization of PARP inhibitors, these services help researchers navigate the complexities of cancer treatment development efficiently. For further inquiries and to learn how our solutions can help accelerate your research goals, please contact us today.